A carregar...

Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study

Immune checkpoint inhibitors (ICIs) elicit antitumour effects by activating the host immunity and cause immune-related adverse events (irAEs). ICI-related interstitial lung disease (ICI-ILD) is a fatal irAE that is difficult to treat; moreover, its incidence is relatively higher in patients with lun...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Okada, Naoto, Matsuoka, Rie, Sakurada, Takumi, Goda, Mitsuhiro, Chuma, Masayuki, Yagi, Kenta, Zamami, Yoshito, Nishioka, Yasuhiko, Ishizawa, Keisuke
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7426925/
https://ncbi.nlm.nih.gov/pubmed/32792640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-70743-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!